|
CDC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36520000004747E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.75760000015779E-07 |
| Normal-vs-Stage2 |
2.680200E-03 |
| Normal-vs-Stage3 |
9.522900000003E-05 |
| Normal-vs-Stage4 |
2.755800E-03 |
| Stage1-vs-Stage2 |
1.650760E-01 |
| Stage1-vs-Stage3 |
3.636200E-01 |
| Stage1-vs-Stage4 |
7.573600E-02 |
| Stage2-vs-Stage3 |
4.915600E-01 |
| Stage2-vs-Stage4 |
9.210800E-01 |
| Stage3-vs-Stage4 |
4.165200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58649999998573E-06 |
| Normal-vs-AfricanAmerican |
2.482600E-03 |
| Normal-vs-Asian |
3.91400000000486E-05 |
| Caucasian-vs-AfricanAmerican |
9.140400E-01 |
| Caucasian-vs-Asian |
8.333000E-01 |
| AfricanAmerican-vs-Asian |
9.845800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.041430E-04 |
| Normal-vs-Female |
1.15749999995973E-06 |
| Male-vs-Female |
2.276600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.89720000043359E-07 |
| Normal-vs-Age(41-60Yrs) |
2.211200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.592210E-04 |
| Normal-vs-Age(81-100Yrs) |
1.036020E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.553900E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.969840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.234400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.741010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.867800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.706000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.908600E-01 |
| Classical-VS-Follicular |
2.898200E-01 |
| Classical-VS-Other |
4.900400E-01 |
| Classical-VS-Normal |
8.54890000012709E-07 |
| Tall-VS-Follicular |
5.842200E-01 |
| Tall-VS-Other |
4.845200E-01 |
| Tall-VS-Normal |
2.788800E-04 |
| Follicular-VS-Other |
7.507400E-01 |
| Follicular-VS-Normal |
6.576200E-04 |
| Other-VS-Normal |
1.598220E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.10200000019911E-07 |
| Normal-vs-N1 |
4.787200E-04 |
| N0-vs-N1 |
5.659000E-01 |
|
|
